11.4 Evaluating the Effectiveness of the Plan of Care
Key Takeaways
Task IV.2 is worth 7 scored items, and its first skill statement — evaluating the effectiveness of the current treatment plan — requires comparing observed outcomes against the goals set in Task IV.1 rather than restating what was done.
Objective, repeatable measures make evaluation possible: wear time in days, DET peristomal score, output volume in mL per 24 hours, number of unplanned changes per week, and demonstrated self-care steps.
Wear time is the single most informative composite indicator in ostomy care, because it integrates seal quality, contour, effluent chemistry, and technique into one number the patient can report.
Evaluation must be scheduled at the time the plan is written; an unscheduled reassessment becomes a complaint-driven visit, by which point skin damage has usually already occurred.
A plan that met its goal is evaluated too: confirming success and identifying which element produced it is what allows the intervention to be sustained rather than accidentally abandoned.
Evaluating the Effectiveness of the Plan of Care
Quick Summary: Task IV.2 reads: "Evaluate the patient-centered plan of care by using periodic assessments to promote optimal ostomy, continent diversion, fistula, or percutaneous tube/drain management." Its three skill statements — evaluate effectiveness, interpret patient responses, modify interventions — form a closed loop. This section covers the first; the next section covers the other two.
Evaluation Is a Comparison, Not a Summary
The most common documentation failure is writing an evaluation that summarises activity:
"Patient seen. Pouch changed. Skin reviewed. Education reinforced."
Nothing in that note can be evaluated, because it states what was done rather than what was achieved. A real evaluation names the goal, states the observed result, and reaches a verdict:
"Goal: peristomal skin intact, DET 0, by two weeks. Observed: DET 4 (D2 E1 T1), erythema at the 6 o'clock position with effluent undermining. Verdict: goal not met; seal failing inferiorly."
That structure — goal, observation, verdict — is what Task IV.2 is testing, and it is what makes the next step, modification, possible.
The Measures That Make Evaluation Possible
| Indicator | What it tells you | Practical target |
|---|---|---|
| Wear time (days) | Composite of seal quality, contour, effluent, and technique | Typically 3–4 days for a barrier; a fall from 4 days to 1 is a signal, whatever the absolute number |
| DET score | Structured peristomal skin status: Discoloration, Erosion, Tissue overgrowth | 0 is intact; any rise between visits means the plan is failing |
| Output volume (mL/24 h) | Fluid balance, adaptation, high-output risk | Mature ileostomy roughly 500–1,000 mL/day; sustained values above about 1,200–1,500 mL/day indicate high output |
| Unplanned changes per week | Real-world reliability of the system | Any unplanned change is a data point; a pattern is a plan failure |
| Self-care steps demonstrated | Progress toward autonomy | Track against the graded sequence, not as a yes/no |
| Hydration markers | Urine output, weight trend, orthostatic symptoms, renal function | Urine output above roughly 1,000 mL/day is a practical patient-facing target |
| Quality-of-life measure | Whether clinical success translates to lived improvement | Repeat the same validated instrument used at baseline |
Two features make these useful: they are numeric or scored, and they are repeatable by a different clinician. "Skin looks better" fails both tests.
Why Wear Time Deserves Special Attention
Wear time is the most efficient single question in an ostomy follow-up, because almost every failure mode reduces it:
- A contour problem shortens it by undermining the seal.
- High output shortens it by overwhelming the barrier.
- Poor technique shortens it through gaps and wrinkles.
- Peristomal moisture shortens it by preventing adhesion.
- An oversized aperture shortens it by exposing skin to effluent.
So a patient who reports that wear time dropped from four days to one has already told you the plan is failing, before any physical assessment. The examination step then determines which of the mechanisms above is responsible.
Wear time also has an upper bound worth knowing: extending wear beyond manufacturer guidance to save supplies is a false economy, because barrier erosion eventually exposes skin to effluent and the resulting damage costs far more wear time than it saved.
Timing: Evaluation Is Scheduled When the Plan Is Written
An evaluation point that is not scheduled does not happen. Reasonable scheduling anchors:
INPATIENT ....... daily while output and stoma size are changing
DISCHARGE ....... confirm supply plan executed, self-care level achieved
FIRST 2 WEEKS ... highest-risk window - stoma oedema resolving, size changing fast
6-8 WEEKS ....... stoma has reached mature size - RE-MEASURE and re-fit
THEN ............ at every change in status: new leak pattern, new medication,
new complication, weight change, pregnancy, new therapy
The six-to-eight-week re-measurement is a fixed obligation rather than an optional check. Stomal oedema resolves over that period, and a barrier aperture sized in the first postoperative week will be substantially too large by then — an oversized aperture being one of the most common causes of chronic peristomal irritant dermatitis.
Evaluating Success, Not Only Failure
When a goal has been met, evaluation still has work to do: identify what produced the success so it can be preserved. A patient achieving four-day wear time after switching to a mouldable barrier and a barrier ring should have that specific combination recorded by product, because a well-meaning substitution at the next supply reorder can silently undo it. Documenting the reason a product was chosen protects the patient from being switched to an equivalent-looking alternative that does not solve their particular contour problem.
Evaluation Across the Non-Ostomy Blueprint Content
The same discipline applies to the other three device categories the blueprint names:
- Continent diversions: catheterisation interval achievable and adhered to, absence of over-distension symptoms, absence of infection.
- Fistulae: output trend, perifistular skin status, whether containment is holding, nutritional markers.
- Percutaneous tubes and drains: peritubular skin status, dressing or pouch change frequency, securement holding, output character and volume.
In every case the question is the same: did the goal we set actually happen, and how do we know?
Which note best represents an evaluation of the effectiveness of an ostomy plan of care?
Ostomy nurse visited. Pouch changed without difficulty. Education reinforced. Will follow up.
Goal was peristomal skin intact with DET 0 at two weeks. Observed DET 4 with erosion at the 6 o'clock position and effluent undermining the barrier inferiorly. Goal not met; seal failing inferiorly.
Patient appears to be adjusting well and reports feeling more confident with the stoma.
Continue current pouching system and reassess as needed.
A patient with an ileostomy reports that barrier wear time has fallen from four days to one day over the past fortnight. How should the ostomy nurse interpret this single piece of information?
As a reliable indicator that the plan is failing, since almost every seal failure mechanism shortens wear time, prompting assessment to determine which mechanism is responsible.
As expected variation that requires no action unless the patient reports pain.
As evidence that the patient has become careless with technique, warranting repeat education alone.
As an indication to double the supply order so the patient can change more often.
Why is a re-measurement and re-fit appointment scheduled at approximately six to eight weeks postoperatively?
Because insurance authorisation for ostomy supplies typically expires at eight weeks.
Because stomal oedema resolves over that period and the stoma reaches its mature size, so a barrier aperture cut in the first postoperative week is by then substantially oversized.
Because peristomal skin cannot be assessed reliably before eight weeks.
Because patients are not permitted to change their own pouch until eight weeks have elapsed.
A patient's peristomal skin has remained intact with a DET score of 0 and consistent four-day wear time since switching to a mouldable barrier with a barrier ring. What should the evaluation include?
Nothing further, since evaluation is required only when a goal has not been met.
A change to a different product line to confirm that the improvement was not coincidental.
A recommendation to extend wear time well beyond manufacturer guidance to reduce supply use.
A record of the specific products and the clinical reason they were chosen, so that a later substitution to a superficially equivalent product does not silently undo the result.
Sections you finish are checked off in the contents.